Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma.

Details

Language :

English

ISSN :

03618609

Volume :

99

Issue :

9

Database :

Complementary Index

Journal :

American Journal of Hematology

Publication Type :

Academic Journal

Accession number :

178835233

Full Text :

https://doi.org/10.1002/ajh.27382